Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations

Published:2019-01 Issue: Volume:106 Page:54-60
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Singer Christian F.^ORCID,Balmaña Judith,Bürki Nicole,Delaloge Suzette^ORCID,Filieri Maria Elisabetta,Gerdes Anna-Marie,Grindedal Eli Marie,Han Sileni^ORCID,Johansson Oskar,Kaufman Bella,Krajc Mateja,Loman Niklas,Olah Edith,Paluch-Shimon Shani,Plavetic Natalija Dedic,Pohlodek Kamil^ORCID,Rhiem Kerstin,Teixeira Manuel^ORCID,Evans D. Gareth^ORCID

Funder

AstraZeneca

Pfizer

Amgen

Novartis

NIHR

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cancer incidence in five continents, vol. XI (electronic version);Bray,2017

2. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;J Am Med Assoc,2017

3. Meta-analysis of BRCA1 and BRCA2 penetrance;Chen;J Clin Oncol,2007

4. Impact that timing of genetic mutation diagnosis has on surgical decision making and outcome for BRCA1/BRCA2 mutation carriers with breast cancer;Chiba;Ann Surg Oncol,2016

5. A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women;Cortesi;Ann Oncol,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape;Current Oncology Reports;2024-06-01

2. Learning from cancer to address COVID-19;Biologia Futura;2023-06

3. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients;Breast Cancer Research and Treatment;2023-03-29

4. Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-02

5. A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer;Breast Care;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3